Literature DB >> 17475257

Chaperonopathies and chaperonotherapy.

Alberto J L Macario1, Everly Conway de Macario.   

Abstract

The study of molecular chaperones (genetics, structure, location, physiology, pathology, and therapeutics) has developed into a science with specific objectives, methods, and hypotheses, a discipline we called chaperonology. Subdisciplines of chaperonology include the study of pathological chaperones (chaperonopathies) and the analysis of their genes in sequenced genomes (chaperonomics). Chaperonopathies are pathological conditions in which one type of chaperone is deficient due to a genetic or acquired defect that modifies the chaperone's structure and/or makes the chaperone unavailable for functioning when needed. Experimental and clinical data show that chaperones and their genes can be used for treating various pathological conditions, thus justifying the development of chaperonotherapy. We discuss recent work showing that chaperonotherapy is on solid foundations: the data demonstrate that molecular chaperones counteract pathogenetic mechanisms in disease and during stress.

Mesh:

Substances:

Year:  2007        PMID: 17475257     DOI: 10.1016/j.febslet.2007.04.030

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Protein folding: are we there yet?

Authors:  A Clay Clark
Journal:  Arch Biochem Biophys       Date:  2008-01-01       Impact factor: 4.013

2.  Protein profile and alpha-lactalbumin concentration in the milk of standard and transgenic goats expressing recombinant human butyrylcholinesterase.

Authors:  H Baldassarre; M Schirm; J Deslauriers; C Turcotte; V Bordignon
Journal:  Transgenic Res       Date:  2009-03-19       Impact factor: 2.788

Review 3.  A career pathway in protein folding: from model peptides to postreductionist protein science.

Authors:  Lila M Gierasch
Journal:  Protein Sci       Date:  2011-04-04       Impact factor: 6.725

4.  Alterations in molecular chaperones and eIF2alpha during lung endothelial cell apoptosis.

Authors:  Qing Lu; Matthew Jankowich; Julie Newton; Elizabeth O Harrington; Sharon Rounds
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-01-22       Impact factor: 5.464

5.  In vivo imaging of the effect of LPS on arterial endothelial cells: molecular imaging of heat shock protein 60 expression.

Authors:  Marius C Wick; Christina Mayerl; Aleksandar Backovic; Ruurd van der Zee; Werner Jaschke; Hermann Dietrich; Georg Wick
Journal:  Cell Stress Chaperones       Date:  2008-05-09       Impact factor: 3.667

6.  Polymorphisms in the Hsp70 gene locus are genetically associated with systemic lupus erythematosus.

Authors:  Barbara G Fürnrohr; Sven Wach; Jennifer A Kelly; Martin Haslbeck; Christian K Weber; Christian M Stach; Axel J Hueber; Daniela Graef; Bernd M Spriewald; Karin Manger; Martin Herrmann; Kenneth M Kaufman; Summer G Frank; Ellen Goodmon; Judith A James; Georg Schett; Thomas H Winkler; John B Harley; Reinhard E Voll
Journal:  Ann Rheum Dis       Date:  2010-05-24       Impact factor: 19.103

7.  Personalized biochemistry and biophysics.

Authors:  Brett M Kroncke; Carlos G Vanoye; Jens Meiler; Alfred L George; Charles R Sanders
Journal:  Biochemistry       Date:  2015-04-15       Impact factor: 3.162

Review 8.  Barcoding heat shock proteins to human diseases: looking beyond the heat shock response.

Authors:  Vaishali Kakkar; Melanie Meister-Broekema; Melania Minoia; Serena Carra; Harm H Kampinga
Journal:  Dis Model Mech       Date:  2014-04       Impact factor: 5.758

Review 9.  DNAJ Proteins in neurodegeneration: essential and protective factors.

Authors:  Christina Zarouchlioti; David A Parfitt; Wenwen Li; Lauren M Gittings; Michael E Cheetham
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-19       Impact factor: 6.237

10.  hsp70 genes in the human genome: Conservation and differentiation patterns predict a wide array of overlapping and specialized functions.

Authors:  Luciano Brocchieri; Everly Conway de Macario; Alberto J L Macario
Journal:  BMC Evol Biol       Date:  2008-01-23       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.